Financials Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-31 am EDT 5-day change 1st Jan Change
7,040 JPY +0.92% Intraday chart for Shionogi & Co., Ltd. +1.72% +3.56%

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,130,768 1,615,227 1,794,318 2,270,169 1,759,071 1,995,780 - -
Enterprise Value (EV) 1 1,804,875 1,414,518 1,526,132 2,022,423 1,459,258 2,197,065 1,453,345 1,375,685
P/E ratio 16.1 x 13.4 x 16.3 x 19.9 x 9.62 x 13.9 x 13 x 12.5 x
Yield 1.37% 1.94% 1.81% 1.53% 2.26% 2.06% 2.36% 2.39%
Capitalization / Revenue 5.86 x 4.85 x 6.04 x 6.77 x 4.12 x 5.05 x 4.62 x 4.48 x
EV / Revenue 4.96 x 4.24 x 5.14 x 6.04 x 3.42 x 5.05 x 3.37 x 3.09 x
EV / EBITDA 11.4 x 9.84 x 11.5 x 16 x 8.78 x 12.8 x 8.39 x 7.84 x
EV / FCF 13 x 11.6 x 14.7 x 345 x 11.3 x 9.33 x 8.72 x 8.71 x
FCF Yield 7.71% 8.62% 6.8% 0.29% 8.88% 10.7% 11.5% 11.5%
Price to Book 3.2 x 2.11 x 2.12 x 2.33 x 1.6 x 1.78 x 1.5 x 1.42 x
Nbr of stocks (in thousands) 310,970 303,785 301,465 301,483 294,307 283,491 - -
Reference price 2 6,852 5,317 5,952 7,530 5,977 7,040 7,040 7,040
Announcement Date 5/9/19 5/11/20 5/10/21 5/11/22 5/10/23 5/13/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 363,721 333,371 297,177 335,100 426,684 435,081 431,788 445,444
EBITDA 1 157,700 143,682 132,238 126,700 166,168 171,610 173,205 175,465
EBIT 1 138,500 130,628 117,438 110,300 149,003 153,310 153,270 155,786
Operating Margin 38.08% 39.18% 39.52% 32.92% 34.92% 35.24% 35.5% 34.97%
Earnings before Tax (EBT) 1 170,343 158,516 143,018 126,300 220,332 198,283 194,458 199,472
Net income 1 132,800 122,193 111,858 114,200 184,965 162,030 153,797 159,150
Net margin 36.51% 36.65% 37.64% 34.08% 43.35% 37.24% 35.62% 35.73%
EPS 2 424.3 395.7 365.0 378.8 621.3 558.5 540.7 565.0
Free Cash Flow 1 139,136 121,986 103,778 5,864 129,575 163,131 166,762 158,025
FCF margin 38.25% 36.59% 34.92% 1.75% 30.37% 36.64% 38.62% 35.48%
FCF Conversion (EBITDA) 88.23% 84.9% 78.48% 4.63% 77.98% 90.63% 96.28% 90.06%
FCF Conversion (Net income) 104.77% 99.83% 92.78% 5.13% 70.05% 101.01% 108.43% 99.29%
Dividend per Share 2 94.00 103.0 108.0 115.0 135.0 160.0 165.9 168.2
Announcement Date 5/9/19 5/11/20 5/10/21 5/11/22 5/10/23 5/13/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2020 S2 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4
Net sales 1 160,877 174,081 148,452 76,120 145,085 74,541 115,500 71,800 78,900 150,779 187,568 88,337 109,312 121,230 230,542 106,279 98,300 204,539 99,382 109,800 199,770 115,700 110,586
EBITDA 1 - - - - - - - - - - - - - - - 45,198 19,460 - 42,900 39,000 - 57,200 39,341
EBIT 1 58,161 67,070 55,308 23,870 42,664 17,758 49,900 12,400 15,800 28,224 118,249 2,530 46,585 51,521 98,106 40,631 14,600 55,204 34,440 38,067 69,943 46,467 40,014
Operating Margin 36.15% 38.53% 37.26% 31.36% 29.41% 23.82% 43.2% 17.27% 20.03% 18.72% 63.04% 2.86% 42.62% 42.5% 42.55% 38.23% 14.85% 26.99% 34.65% 34.67% 35.01% 40.16% 36.18%
Earnings before Tax (EBT) 1 67,386 91,178 67,189 27,891 50,832 23,952 51,500 40,300 27,700 67,978 130,808 21,546 55,704 59,899 115,603 48,884 33,800 82,680 46,587 50,300 88,843 58,400 47,570
Net income 1 51,616 69,679 49,381 20,893 53,131 17,869 43,200 34,700 22,500 57,264 100,465 27,236 42,562 48,031 90,593 36,629 34,800 71,437 35,887 38,200 67,793 44,500 36,120
Net margin 32.08% 40.03% 33.26% 27.45% 36.62% 23.97% 37.4% 48.33% 28.52% 37.98% 53.56% 30.83% 38.94% 39.62% 39.3% 34.46% 35.4% 34.93% 36.11% 34.79% 33.94% 38.46% 32.66%
EPS 2 165.8 - 160.8 69.30 176.2 59.27 143.2 115.2 75.04 190.2 337.6 93.50 144.6 164.0 308.6 127.2 122.6 - 120.6 122.0 226.0 145.3 178.8
Dividend per Share 2 50.00 - 53.00 - 55.00 - - - - 60.00 - - - 75.00 75.00 - 85.00 - - 80.00 - - 80.00
Announcement Date 10/30/19 5/11/20 10/30/20 11/1/21 11/1/21 1/31/22 5/11/22 8/1/22 10/31/22 10/31/22 1/30/23 5/10/23 7/31/23 10/31/23 10/31/23 1/31/24 5/13/24 5/13/24 - - - - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 325,893 200,709 268,186 247,746 299,813 473,352 542,435 620,095
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 139,136 121,986 103,778 5,864 129,575 163,131 166,763 158,025
ROE (net income / shareholders' equity) 20.9% 15.5% 13.9% 12.5% 17.8% 13.9% 12% 12%
ROA (Net income/ Total Assets) 22.2% 19.6% 11.9% 10.6% 17.9% 14.5% 11.2% 10.3%
Assets 1 598,424 625,008 936,340 1,074,793 1,033,572 1,114,907 1,373,184 1,542,151
Book Value Per Share 2 2,144 2,517 2,807 3,236 3,738 4,357 4,687 4,958
Cash Flow per Share 2 477.0 441.0 413.0 433.0 679.0 622.0 657.0 658.0
Capex 1 6,548 9,954 27,400 26,185 11,858 27,963 22,217 23,738
Capex / Sales 1.8% 2.99% 9.22% 7.81% 2.78% 6.28% 5.15% 5.33%
Announcement Date 5/9/19 5/11/20 5/10/21 5/11/22 5/10/23 5/13/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,040 JPY
Average target price
7,967 JPY
Spread / Average Target
+13.17%
Consensus
  1. Stock Market
  2. Equities
  3. 4507 Stock
  4. Financials Shionogi & Co., Ltd.